Đang chuẩn bị liên kết để tải về tài liệu:
Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

A substantial number of breast cancer patients are identified as being at high risk of developing metastatic disease. With increasing number of targeted therapeutics entering clinical trials, chronic administration of these agents may be a feasible approach for the prevention of metastases within this subgroup of patients. |

TÀI LIỆU LIÊN QUAN

báo cáo hóa học:" Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines"

báo cáo khoa học: " Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET"

Báo cáo y học: "Preclinical evaluation of lime juice as a topical microbicide candidate"

Ebook Hybrid imaging in cardiovascular medicine: Part 2

Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents

Establishment of patient-derived gastric cancer xenografts: A useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways

Safety evaluation of an anti-tumor necrosis factor-alpha receptor fusion protein in sprague dawley rats

Evaluation of single step TaqMan real-time PCR assay lateral to conventional RT-PCR and antigen-capture ELISA for pre-clinical detection of classical swine fever virus

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro